• Entacavir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical stability of the potent antiviral API.

    Active IngredientStrengthPrimary Clinical Function
    Entecavir (as Monohydrate) USP/Ph.Eur.0.5 mgThe Global Nucleoside-Naive Standard: The definitive ultra-micro-dose utilized for the daily, lifelong suppression of HBV in patients who have never received prior antiviral therapy.
    Entecavir (as Monohydrate) USP/Ph.Eur.1.0 mgThe Refractory & Cirrhosis Standard: Double-strength therapeutic payload utilized specifically for patients with Lamivudine-resistant HBV viremia or those suffering from decompensated liver cirrhosis.
    ExcipientsLactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Magnesium Stearate / Premium Polymeric FilmDiluent / Binder / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing advanced multi-stage geometric dilution to ensure the microscopic 0.5mg payload is flawlessly distributed throughout the tablet matrix, preventing toxic “hot spots” or sub-therapeutic failures)

    *Pack Sizes: 3×10 Alu-Alu Blisters or Bottles of 30 (Optimized specifically for strict 30-day chronic hepatology dispensing regimens).

  • Favipiravir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pyrazinecarboxamide derivative.

    Active IngredientStrengthPrimary Clinical Function
    Favipiravir USP/Ph.Eur.200 mgThe Global Outbreak Standard: Base therapeutic unit utilized for standard, highly flexible titration during acute viral hemorrhagic fevers or novel influenza outbreaks.
    Favipiravir USP/Ph.Eur.400 mg / 800 mgThe Pill-Burden Reduction Macrodose: Massive therapeutic payload engineered specifically to solve the severe “Day 1 Loading Dose” compliance nightmare (allowing a patient to take two 800mg pills instead of eight 200mg pills).
    ExcipientsMicrocrystalline Cellulose / Crospovidone / Povidone K-30 / Colloidal Silicon Dioxide / Sodium Stearyl Fumarate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Glidant / Lubricant (Engineered specifically utilizing advanced high-shear wet granulation to compress massive, bulky API doses into smooth, easily swallowable tablets, finished with a heavy film-coat to lock out tropical humidity)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Complete Therapy “Outbreak Kits” (e.g., 34-tablet or 40-tablet regimen boxes).

  • Ganciclovir Capsules

    Free

    Ganciclovir capsules (commonly found in 250 mg and 500 mg strengths) contain the active antiviral drug ganciclovir, a synthetic guanine derivative used to treat and prevent cytomegalovirus (CMV) infections

  • Ganciclovir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.

    Active IngredientStrengthPrimary Clinical Function
    Ganciclovir USP/Ph.Eur.250 mgRenal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance).
    Ganciclovir USP/Ph.Eur.500 mgGlobal Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric FilmDiluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust)

    *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).

  • Ledipasvir & sofosbuvir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.

    Active IngredientStrengthPrimary Clinical Function
    Ledipasvir USP/Ph.Eur.90 mgThe NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes.
    Sofosbuvir USP/Ph.Eur.400 mgThe NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes.
    ExcipientsCopovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry FilmBinder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption)

    *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).

  • Ledipasvir Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.

    Active IngredientStrengthPrimary Clinical Function
    Ledipasvir USP/Ph.Eur.90 mgGlobal Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle.
    ExcipientsCopovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry FilmSolubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability)

    *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).

  • Oseltamivir Tablet

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Hard Gelatin Capsule, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the hygroscopic phosphate salt.

    Active IngredientStrengthPrimary Clinical Function
    Oseltamivir Phosphate USP/Ph.Eur.75 mg (Equivalent to Oseltamivir free base)Global Standard: Target adult dose for rapid treatment and prophylaxis of Influenza A/B.
    ExcipientsPregelatinized Starch / Croscarmellose Sodium / Povidone / Sodium Stearyl FumarateDiluent / Superdisintegrant (Engineered for immediate gastric capsule rupture and rapid systemic absorption)

    *Pack Sizes: 1×10 Blisters (Optimized perfectly for the standard 5-day acute treatment regimen of two capsules daily).

  • Ribavirin Tablets

    Free

    Product Composition & Strength

    We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu or heavy-density PVC/PVDC blister strips to ensure the stability of the active nucleoside analog and protect handlers from exposure.

    Active IngredientStrengthPrimary Clinical Function
    Ribavirin USP/Ph.Eur.200 mgGlobal Clinical Standard: Base titration unit for precise, weight-based antiviral dosing.
    Ribavirin USP/Ph.Eur.400 mgHigh-dose unit to drastically improve pill-burden compliance in heavy patients.
    ExcipientsMicrocrystalline Cellulose / Croscarmellose Sodium / Povidone / Magnesium StearateDiluent / Superdisintegrant / Binder (Engineered for immediate gastric dissolution and rapid systemic absorption)

    *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for high-dose, weight-based daily regimens requiring 4 to 6 tablets per day).

  • Sofosbuvir 400 mg tablet + Ledipasvir 90 mg Tablet

    Free

    A tablet containing Sofosbuvir 400 mg + Ledipasvir 90 mg is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection, specifically targeting genotypes 1, 4, 5, and 6.

  • Sofosbuvir 400mg+ Velpatasvir 100 mg Tablet

    Free

    Sofosbuvir 400 mg + Velpatasvir 100 mg tablet is a fixed-dose combination antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection across all major genotypes (1 through 6).

  • Sofosbuvir Tablet

    Free

    Sofosbuvir 400 mg tablet is a direct-acting antiviral medication used to treat chronic Hepatitis C Virus (HCV) infection. It belongs to the nucleotide polymerase inhibitor class and works by blocking the NS5B protein, which the virus needs to replicate.

  • Valganciclovir Tablet

    Free

    Valganciclovir tablets (most commonly available in 450 mg strength) contain valganciclovir hydrochloride as the active antiviral ingredient. It is a “prodrug” that the body converts into ganciclovir to treat or prevent cytomegalovirus (CMV) infections.